TickerFactsScreenerDevelopers

Cadrenal Therapeutics, Inc. (CVKD) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2023: -$3.53M2024: -$7.36M2025: -$12.60M-$12.60M
2023Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$12.60M-71.3%
2024-$7.36M-108.4%
2023-$3.53M—